1st TIF Pan American Conference and 2nd RAIN Summit: A Milestone of Hope
Thalassaemia International Federation (TIF) shared a grateful post on LinkedIn:
”What an unforgettable journey in Washington D.C.!
As we look back on the 1st TIF Pan American Conference and the 2nd RAIN Summit, we are deeply grateful to our incredible Sponsors who helped turn this vision into reality.
Your generous support empowered vital conversations and new connections among the Thalassaemia, SCD, and Rare Anaemias communities across the Americas.
Thank you for standing with us — for care, for science, for hope!”
The 1st TIF Pan American Conference and 2nd RAIN Summit in Washington D.C. marked an unforgettable milestone for the Thalassaemia, SCD, and Rare Anaemias communities.
TIF thanked all the sponsors: Agios Pharmaceuticals, Bristol Myers Squibb, Vertex Pharmaceuticals, bluebird bio, Chiesi Global Rare Diseases, Novo Nordisk and Sanofi.
Thanks to the support of dedicated sponsors, vital conversations and new collaborations flourished—advancing care, science, and hope across the Americas.
Do not miss the latest updates on the waves in the hematology field, read Hemostasis Today.
-
Dec 12, 2025, 14:478 Posts Not to Miss From the ASH 2025 – Marc Carrier
-
Dec 12, 2025, 10:17Alyssa George on Clinical and Economic Impact of a Eptacog Beta
-
Dec 12, 2025, 09:53Ivan Budnik Awarded AHA Postdoctoral Fellowship! Aiming to Improve DVT Long-term Outcomes
-
Dec 12, 2025, 09:34Giles Platford on Baby Big: Plasma-Derived Drug Against Infant Botulism
-
Dec 12, 2025, 09:22Matteo Foschi Presents The New Expert Guidance on Minor Ischemic Stroke
-
Dec 12, 2025, 07:00Umberto Pensato on Cancer and Stroke
-
Dec 12, 2025, 06:48Steve Tuplin on A New Era in Haemophilia A Care: Reflections from ASH25
-
Dec 12, 2025, 06:30Anirban Sen Gupta on Synthetic Platelets
-
Dec 12, 2025, 05:59Gaetan Duport: A New Legislation for Medicines in Europe